Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07424469 · ClinicalTrials.gov registry record · NA
Foregut Leaks-Role of Microbiome
A NA study of Gastrointestinal Diseases, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07424469: Recruiting NA study of Gastrointestinal Diseases, sponsored by Baylor Research Institute.
NCT07424469 is a NA study of Gastrointestinal Diseases that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 50 participants, below the 36,413-participant average among 14 other Gastrointestinal Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07424469, a NA study of Gastrointestinal Diseases, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Aims 1. To understand the microbial composition involved with foregut leaks 2. To define the virulence changes in the microbiota following foregut leaks 3. To identify host response mechanisms and how they change with interventions 4. Utilize this information to improve patient outcomes
Primary Outcome
change in virulence factors, microbial response to treatment modalities
Conditions Studied
Interventions
- OTHER Biopsy and fluid samples
Study Locations (1)
Texas
- Baylor Scott & White Center for Advanced Surgery - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-08-14 |
| Est. Completion | 2028-06-01 |
| Phase | NA |
What NCT07424469 shows while recruiting
NCT07424469 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 36,413-participant average among 14 other Gastrointestinal Diseases trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Gastrointestinal Diseases appearing as the primary indexed condition, and to 1 intervention - of which Biopsy and fluid samples is the first listed.
NCT07424469 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07424469 about?
NCT07424469 is a clinical study titled "Foregut Leaks-Role of Microbiome". Aims 1. To understand the microbial composition involved with foregut leaks 2. To define the virulence changes in the microbiota following foregut leaks 3. To identify host response mechanisms and how they change with interventions 4. Utilize this information to improve patient outcomes
What is the current status of trial NCT07424469?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2020-08-14. Estimated completion is 2028-06-01.
What conditions does trial NCT07424469 study?
This clinical trial studies the following conditions: Gastrointestinal Diseases.
What interventions are being tested in trial NCT07424469?
The interventions under investigation include: Biopsy and fluid samples (OTHER).
Who is sponsoring clinical trial NCT07424469?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07424469 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07424469's enrollment target sits among peer trials
50 12th of 14 higher than 3 of 14 other Gastrointestinal Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastrointestinal Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trans-nasal Endoscopy for Bariatric Patients
RECRUITING · NA
-
Virtual Reality for Non-cardiac Chest Pain
RECRUITING · NA
-
Immune Responses to Gluten
RECRUITING · NA
-
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
RECRUITING · NA
-
A Randomized Controlled Trial of a School Disinfection and Hand Hygiene Program
COMPLETED · NA
-
A Trial of Tap Water Treatment in the Elderly
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI